Page last updated: 2024-11-06

hydrocortisone acetate and Leukemia

hydrocortisone acetate has been researched along with Leukemia in 1 studies

hydrocortisone acetate: RN given refers to cpd without isomeric designation

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ELIEL, LP1
PEARSON, OH1
WHITE, FC1

Other Studies

1 other study available for hydrocortisone acetate and Leukemia

ArticleYear
The comparative metabolic effects of ACTH, cortisone acetate, and "compound F" acetate in a patient with chronic lymphatic leukemia.
    The Journal of clinical investigation, 1950, Volume: 29, Issue:6

    Topics: Acetates; Adrenocorticotropic Hormone; Cortisone; Hydrocortisone; Leukemia; Leukemia, Lymphocytic, C

1950